Press Releases Translations 12 Jun 2026 La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Statements 9 Jun 2026 DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 14 May 2026 Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study PLOS Neglected Tropical Diseases
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Scientific articles 10 May 2024 Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia Journal of Antimicrobial Chemotherapy
Scientific articles 8 May 2024 Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns Helyon
Scientific articles 7 May 2024 A scoping literature review of global dengue age-stratified seroprevalence data: estimating dengue force of infection in endemic countries eBioMedicine
Scientific articles 1 May 2024 Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 30 Apr 2024 N-Pyrazolyl- and N-Triazolylamines and -Ureas as antileishmanial and antitrypanosomal drugs ChemMedChem
Scientific articles 22 Apr 2024 Representations of Chagas disease among Bolivian immigrants in the city of São Paulo Frontiers in Tropical Diseases
Scientific articles 19 Apr 2024 Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model PLOS Neglected Tropical Diseases
Scientific articles 16 Apr 2024 Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform PLOS Neglected Tropical Diseases
Scientific articles 2 Apr 2024 AI is a viable alternative to high throughput screening: a 318-target study Nature Scientific Reports
Scientific articles 29 Mar 2024 Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148 Organic Process Research & Development
Scientific articles 26 Mar 2024 High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae eBioMedicine
Scientific articles 26 Mar 2024 Towards enhanced control of mycetoma: a roadmap to achieve the UN’s sustainable development goals by 2030 Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 15 Mar 2024 Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers Clinical and Translational Science
Scientific articles 21 Feb 2024 Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development PLOS Neglected Tropical Diseases
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ACS Central Science
Scientific articles 31 Jan 2024 Onchocerciasis drug discovery: In vitro evaluation of FDA-approved drugs against onchocerca gutturosa in Gambia Pharmaceutics